- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Alvotech SA (ALVO)
Alvotech SA stock price live, this page displays NASDAQ ALVO stock exchange data. View the ALVO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Alvotech SA real time stock price chart below.
What Is the Alvotech SA Stock Price Today?
The Alvotech SA stock price today is 1,025.00.
What Is the Stock Symbol for Alvotech SA?
The stock symbol for Alvotech SA is ""ALVO.""
What Stock Exchange Does Alvotech SA Trade On?
Alvotech SA is listed and trades on the NASDAQ stock exchange.
Is Alvotech SA a Good Stock to Buy?
Determining whether Alvotech SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ALVO quote. (ISIN: LU2458332611)
What Is the Alvotech SA Stock Price Today?
The Alvotech SA stock price today is 1,025.00.
What Is the Stock Symbol for Alvotech SA?
The stock symbol for Alvotech SA is ""ALVO.""
What Stock Exchange Does Alvotech SA Trade On?
Alvotech SA is listed and trades on the NASDAQ stock exchange.
Is Alvotech SA a Good Stock to Buy?
Determining whether Alvotech SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ALVO quote. (ISIN: LU2458332611)
1,025.00
+20.00(+1.99%)
Closed·
Fair Value
An estimate of a Alvotech SA's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,000.00
1,040.00
52 wk Range
978.00
1,945.00
ALVO Scorecard
Full Analysis
Net income is expected to grow this year
ALVO is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Alvotech SA's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,000.001,040.00
52 wk Range
978.001,945.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ALVO Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Alvotech SA's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
- Form 6K Alvotech SA For: 9 July
- Investing.com
- Alvotech receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 6K Alvotech SA For: 10 July
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Alvotech SA Company Profile
Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company’s lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, plaque psoriasis, and other indications; AVT04, a biosimilar to Stelara to treat various inflammatory conditions comprising psoriatic arthritis, Crohn’s disease, ulcerative colitis, plaque psoriasis, and other indications; AVT06, a biosimilar to Eylea to treat various conditions, such as age-related macular degeneration, macular edema, and diabetic retinopathy; and AVT03, a biosimilar to Xgeva and Prolia to treat prevent bone fracture, spinal cord compression, and the need for radiation or bone surgery in patients with certain types of cancer, as well as prevent bone loss and increase bone mass. In addition, it offers AVT05, a biosimilar to Simponi and Simponi Aria to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and other indications; AVT16, a biosimilar to an Entyvio product for the treatment of adult patients with moderate to severe ulcerative colitis and moderate to severely active Crohn’s disease; AVT23, a biosimilar to Xolair to treat allergic asthma, chronic spontaneous urticaria (CSU), and nasal polyp; and AVT33, a biosimilar to Keytruda product which is in early phase development. Alvotech was founded in 2013 and is based in Luxembourg, Luxembourg.
Compare ALVO to Peers and Sector
Metrics to compare | ALVO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALVOPeersSector | |
|---|---|---|---|---|
P/E Ratio | 39.5x | −1.9x | −0.5x | |
PEG Ratio | 0.36 | −0.09 | 0.00 | |
Price/Book | −14.4x | 2.0x | 2.6x | |
Price / LTM Sales | 4.4x | 5.4x | 3.3x | |
Upside (Analyst Target) | - | 386.7% | 40.3% | |
Fair Value Upside | Unlock | 29.7% | 5.1% | Unlock |
Earnings
Latest Release
May 08, 2025
EPS / Forecast
0.35 / --
Revenue / Forecast
132.81M / --
People Also Watch
FAQ
What Stock Exchange Does Alvotech SA Trade On?
Alvotech SA is listed and trades on the Iceland Stock Exchange stock exchange.
What Is the Stock Symbol for Alvotech SA?
The stock symbol for Alvotech SA is "ALVO."
What Is the Alvotech SA Market Cap?
As of today, Alvotech SA market cap is 323.18B.
What Is Alvotech SA's Earnings Per Share (TTM)?
The Alvotech SA EPS (TTM) is 0.22.
From a Technical Analysis Perspective, Is ALVO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Alvotech SA Stock Split?
Alvotech SA has split 0 times.
How Many Employees Does Alvotech SA Have?
Alvotech SA has 1012 employees.
What is the current trading status of Alvotech SA (ALVO)?
As of 16 Aug 2025, Alvotech SA (ALVO) is trading at a price of 1,025.00, with a previous close of 1,005.00. The stock has fluctuated within a day range of 1,000.00 to 1,040.00, while its 52-week range spans from 978.00 to 1,945.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.